Manufacturing and insurance coverage points have made it onerous for a lot of members of our group to fill their prescriptions for epinephrine auto-injectors in latest months. However the drug epinephrine itself is just not in brief provide. This has develop into a severe concern for individuals with life-threatening allergic reactions. When individuals who handle life-threatening allergic reactions are in worry for his or her lives as a result of they can not get the drugs they want, our system is damaged.The Bronchial asthma and Allergy Basis of America (AAFA) despatched a letter to the Division of Well being and Human Companies (HHS) to ask them to repair this technique. Learn the letter AAFA despatched to the HHSSenator Richard Blumenthal (D-CT) additionally despatched a letter to HHS on Aug. 27, 2018, additionally requesting motion.You can also contact HHS about this subject. We ask you to signal the letter under so we are able to present HHS the influence of this subject. Our instrument under makes it straightforward so that you can ship as an e-mail message – and you’ll personalize by including your story.Pricey Mr. Secretary:I’m writing to share my considerations about epinephrine auto-injector shortages. My household is impacted by meals allergic reactions, which may result in a life-threatening allergic response that requires instant remedy with epinephrine. I’m one of many many who’ve skilled probably life-threatening fallout from the auto-injector shortages.No less than one insurance coverage firm has began rationing the prescriptions and solely giving one dose as a substitute of the prescribed two doses. I worry one of these apply will proceed and unfold. Please remember the affected person and caregiver perspective when coping with anaphylaxis. It is crucial that individuals with meals allergic reactions have entry to 2 doses of epinephrine always. When you have a baby in class, you want to present the varsity with two doses. You additionally want two doses for house and different places.Lately, the FDA took two actions however these actions is probably not sufficient to assist households like mine. The latest approval of a brand new generic epinephrine auto-injector received’t remedy the present scarcity because the producer has not begun to provide this new generic model. The FDA offered for the extension of expiration dates on the EpiPen® zero.3mg dose however this doesn’t assist kids who use the zero.15mg dose. Colleges could also be reluctant to just accept expired medicines as nicely, so that is placing households in a really hectic scenario.There are solely three choices for epinephrine auto-injectors within the U.S. and presently, there are roadblocks to entry all three. Two of them have manufacturing shortages. The opposite choice doesn’t have a scarcity, however most insurance coverage firms don’t cowl it and it’s only obtainable through a direct supply system – which means, my household can’t simply go to the pharmacy and get this life-saving drugs in the present day.I respectfully request that the Division of Human and Well being Companies have a look at this scarcity subject instantly. I’m conscious of the Bronchial asthma and Allergy Basis of America’s outreach to your workplace and I encourage you to work with them and different stakeholders to give you instant options to open up entry to epinephrine auto-injectors.With just some clicks, you can be part of us in urging the HHS to take motion on epinephrine entry points:AAFA is devoted to bettering the standard of life for individuals with bronchial asthma and allergic ailments by way of help, schooling, advocacy and analysis. We work to lift consciousness and influence coverage modifications to assist enhance and save lives.To help our work, please contemplate giving a donation.